Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Semin Cutan Med Surg ; 28(2): 86-92, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19608058

ABSTRACT

Vitiligo is an acquired dyschromia of the skin in which there is a loss of epidermal melanocytes. The prevalence of vitiligo is approximately 1% in the United States and 0.1-2% worldwide. The exact pathogenesis of vitiligo remains elusive and is likely multifactorial. After completing this update, participants should be able to discuss the epidemiology of vitiligo and summarize the proposed mechanisms for development of this disease. In addition, they should be able to discuss physical findings, approach to the patient, and some of the therapeutic modalities for this disorder.


Subject(s)
Vitiligo/ethnology , Vitiligo/therapy , Asian People , Black People , Humans , Immunosuppressive Agents/therapeutic use , Phototherapy , Vitiligo/classification , Vitiligo/diagnosis , Vitiligo/immunology , Vitiligo/physiopathology
2.
Photodermatol Photoimmunol Photomed ; 20(5): 252-6, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15379876

ABSTRACT

BACKGROUND/PURPOSE: In the previous work, we correlated epidermal hyperplasia with increased epidermal absorption in the 250-400 nm region. During a recent review of that work, the apparent formation of a chromophore, with absorption slightly longer than 400 nm, in the epidermis of irradiated animals was noted. In this study, we have extended the transmission measurement to include the 250-800 nm region. METHODS: Age-matched Skh-1 hairless mice were separated into three groups. One group was irradiated with 6.3 J/cm(2) (0.9 minimal erythemal dose; MED) of solar simulating ultraviolet radiation (SSUVR) five times/week for 2 weeks, then increased to 1.1 MED (7.1 J/cm(2)) for two additional weeks (20-day group). A second 10-day group, added halfway through the protocol, was irradiated with 0.9 MED five times/week for 2 weeks. The control group received no UV irradiation. Routine H&E staining and epidermal absorption spectral analysis were carried out on biopsy specimens from each animal. RESULTS: This work confirms the development or enhancement of a visible chromophore with a maximum absorption at ca 412 nm. This peak appears to be radiation dose dependent. It can be discerned in both the groups, albeit more prominently in the 20-day animals. The absorption is sufficiently strong to impart a yellow to reddish appearance to skin viewed in full spectrum visible light. CONCLUSIONS: Accumulation of such a chromophore in humans may contribute to the coloration of chronically exposed skin. The absorption strength and wavelength location of the peak is strongly suggestive of a heme-like compound. We are currently conducting experiments to further characterize this chromophore.


Subject(s)
Chromogenic Compounds/radiation effects , Skin Pigmentation/radiation effects , Skin/radiation effects , Ultraviolet Rays , Absorption , Animals , Biopsy , Chromogenic Compounds/analysis , Coloring Agents , Dose-Response Relationship, Radiation , Light , Mice , Mice, Hairless , Radiation Dosage , Skin/pathology , Spectrum Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...